D
Lineage Cell Therapeutics, Inc. LCTX
$1.25 $0.086.84% AMEX
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -30.46M -4.14M -3.27M -3.03M -5.76M
Total Depreciation and Amortization 171.00K 164.00K 151.00K 141.00K 142.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 27.11M -643.00K -207.00K 818.00K 1.55M
Change in Net Operating Assets -2.35M -268.00K -3.02M -3.71M -1.11M
Cash from Operations -5.54M -4.89M -6.35M -5.79M -5.18M
Capital Expenditure -14.00K -97.00K -365.00K -112.00K -50.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 0.00 2.00M 3.00M 4.00M -8.74M
Cash from Investing -14.00K 1.90M 2.64M 3.89M -8.79M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -14.00K -14.00K -14.00K -13.00K -14.00K
Issuance of Common Stock -- 5.30M 21.81M 10.00K 119.00K
Repurchase of Common Stock -65.00K -15.00K 0.00 0.00 0.00
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -228.00K -224.00K -58.00K 0.00 --
Cash from Financing -307.00K 5.04M 21.73M -3.00K 105.00K
Foreign Exchange rate Adjustments 293.00K -73.00K 25.00K 38.00K -88.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -5.57M 1.99M 18.05M -1.86M -13.95M